Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Clinic for Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany.
J Neurointerv Surg. 2018 Nov;10(11):1092-1096. doi: 10.1136/neurintsurg-2018-013752. Epub 2018 Mar 19.
The embolization technique can have significant impact on the success of endovascular embolization.
To evaluate the feasibility, embolization characteristics, and embolization extent with a newly developed extra-small micro-balloon catheter in an in vivo and in an in vitro embolization model in comparison with standard microcatheter embolizations.
Twenty-eight embolization procedures were performed in the porcine rete mirabile (RM) and in an in vitro embolization model, using either an extra-small (distal outer diameter 1.6 F) dual-lumen micro-balloon catheter or a standard microcatheter. Precipitating hydrophobic injectable liquid (PHIL) was used as embolic agent. Procedure times, number of injections, required volume of embolic agent, and embolization extent (percentage of embolized RM in postinterventional X-ray scans or number of filled sections of the in vitro model) were assessed. Histopathological analyses were performed.
Total procedure time was significantly shorter (in vivo: 123 s vs 615 s (medians), P=0.001; in vitro: 180 s vs 496 s (medians), P=0.001), number of reflux events was significantly lower (in vivo: 0 vs 9 (medians), P=0.001; in vitro: 0 vs 3 (medians), P=0.001), and embolization extent was significantly higher (in vivo: 96.9% vs 65.6% (medians), P=0.011; in vitro: 26 vs 18 filled sections (medians); P=0.041) for the micro-balloon catheter groups. There was antegrade movement of the PHIL cast after balloon deflation in one in vitro embolization procedure and spontaneous balloon deflation with subsequent reflux in one in vivo embolization procedure.
Extra-small dual-lumen micro-balloon catheters can improve endovascular embolization in comparison with standard microcatheter embolization.
栓塞技术对血管内栓塞的成功有重要影响。
在活体和体外栓塞模型中评估新型超小型微球囊导管的可行性、栓塞特性和栓塞程度,并与标准微导管栓塞进行比较。
在猪的网眼状硬脑膜静脉窦(RM)和体外栓塞模型中进行了 28 次栓塞操作,分别使用超小型(远端外径 1.6F)双腔微球囊导管或标准微导管。使用沉淀疏水性可注射液体(PHIL)作为栓塞剂。评估手术时间、注射次数、栓塞剂所需体积和栓塞程度(介入后 X 射线扫描中栓塞的 RM 百分比或体外模型中充满的节段数)。进行了组织病理学分析。
总手术时间明显缩短(活体:123s 与 615s(中位数),P=0.001;体外:180s 与 496s(中位数),P=0.001),反流事件的数量明显减少(活体:0 与 9(中位数),P=0.001;体外:0 与 3(中位数),P=0.001),栓塞程度明显提高(活体:96.9%与 65.6%(中位数),P=0.011;体外:26 与 18 个充满的节段(中位数),P=0.041)。在一个体外栓塞程序中,球囊充气后 PHIL 铸型发生逆行移动,在一个活体栓塞程序中,球囊自发充气后发生反流。
与标准微导管栓塞相比,超小型双腔微球囊导管可改善血管内栓塞。